Fabtech Cleanrooms Ltd
544332Fabtech Cleanrooms Ltd is strength at full price. The numbers are improving — and a P/E at the 97th percentile of its own range says the market knows.
The sharpest disagreement: profits are rising, but only −31% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (17 weeks in) while the P/E sits at the 97th percentile of its own 2-year range. Underneath, the last four quarters read improving — profit +62.5% year on year, and −31% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Fabtech Cleanrooms Ltd trades at ₹494, in a confirmed uptrend and 17 weeks into that stage. That is +32.3% against its own 200-day average. It sits at 92% of a 52-week range of ₹277 to ₹513. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is in a confirmed uptrend — week 17 of stage 2, confirmed. At ₹494 it trades +32.3% versus its 200-day average and sits at 92% of its 52-week range (₹277–₹513).
Against the market, two honest reads. Cumulative: over the last 5 months the stock moved +79% while the NIFTY 500 moved −4% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Fabtech Cleanrooms Ltd trades at 40.4× P/E, at the pricey end of its own range (97th percentile). Its long-run median P/E is 29.5×, measured across 1.7 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 40.4× is at the pricey end of its own range (97th percentile), against a long-run median of 29.5× measured over 1.7 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Fabtech Cleanrooms Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +46.0% | +20.6% | +25.6% | — |
| Profit | +30.8% | +28.6% | +76.2% | — |
| EPS | +18.9% | −23.4% | −44.8% | — |
4-Factor Sector Score
57.3/100 — rank 32 of 37 in Miscellaneous · 36% evidence confidence · provisional, ranked below fully-evidenced peers
Fabtech Cleanrooms Ltd scores 57.3 out of 100 against the 37 companies it is compared with in Miscellaneous, ranking 32. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 17.6 + 17.4 + 9.9 + 12.4 = 57.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Fabtech Cleanrooms Ltd reported ₹143 Cr of revenue in the Mar 26 quarter, +62.5% year on year. That is the 3rd straight quarter of year-on-year growth. Over 6 years it has compounded at 16.2% a year. The last full year, FY26, came in at ₹219 Cr. The last four reported quarters add to ₹369 Cr.
FY26 revenue came in at ₹219 Cr (+46.0% on the year), capping 6 years at 16.2% compound. The latest quarter (Mar 26) printed ₹143 Cr, +62.5% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +45.6% growth against the decade's 16.2% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Fabtech Cleanrooms Ltd's operating margin is 12.0% in the Mar 26 quarter, +2.0 percentage points against the same quarter a year ago. Across the last four quarters the operating margin has moved −1.0 percentage points. Across 7 fiscal years the operating margin has ranged 2.1% to 11.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 12.0%, +2.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 2.1%–11.0%.
🚨 Why the margin moved: operating margin went −1.1 pp year on year while gross margin went +2.3 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Fabtech Cleanrooms Ltd earned ₹13.0 Cr of net profit in the Mar 26 quarter, +62.5% year on year. Full-year FY26 profit was ₹17.0 Cr. The 6-year compound rate is 27.3%. That is 9.1% of the quarter's revenue. The same quarter a year earlier earned ₹5.0 Cr.
Mar 26 profit was ₹13.0 Cr, +62.5% year on year. On the full year, FY26 printed ₹17.0 Cr (+30.8%), and the 6-year compound rate is 27.3%.
Why profit moved: revenue contributed +62.5% and the margin +2.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +34.2% vs revenue +45.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −31% of Fabtech Cleanrooms Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−17.0 Cr of operating cash against ₹17.0 Cr of profit. After ₹7.0 Cr of capital spending, ₹−24.0 Cr was left as free cash.
FY26: operating cash of ₹−17.0 Cr against reported profit of ₹17.0 Cr, leaving free cash of ₹−24.0 Cr after ₹7.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −31% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −31%: the cash cycle tightened 28 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: the bigger cash user is investment — capital spending ran 2.7× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Fabtech Cleanrooms Ltd's cash conversion cycle runs 142 days in FY26, down from 170 days in FY21. Capital spending ran ₹8.0 Cr over the last 3 years. At FY26 sales of ₹219 Cr each day of that cycle holds about ₹0.6 Cr, so roughly ₹85.0 Cr sits inside the business at any moment.
FY26: debtors at 146 days, inventory at 81 days — roughly 2.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 142 days, tighter than FY21's 170.
The full loop: cash goes out to suppliers and production on day 0; stock waits 81 days to sell; customers pay about 146 days after that; and suppliers themselves are paid at 85 days — netting out to the 142-day cycle.
In money terms: at FY26 sales of ₹219 Cr, each day of the cycle holds about ₹0.6 Cr — so the 142-day loop keeps roughly ₹85.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹8.0 Cr over the last 3 fiscal years against ₹3.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹1.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Fabtech Cleanrooms Ltd earns a ROCE of 19% in FY26. That is up from a trough of 2% in FY21. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 7.8% net margin on 1.18× asset turns.
FY26 ROCE is 19%, recovered from a FY21 trough of 2% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 7.8% net margin × 1.18× asset turns × 1.81× balance-sheet leverage ≈ 16.7% on equity. Margin does its share; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Fabtech Cleanrooms Ltd carries ₹19.0 Cr of borrowings against ₹103 Cr of equity in FY26, a debt-to-equity of 0.18. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹7.0 Cr to ₹19.0 Cr. Capital spending ran ₹8.0 Cr across the last 3 of those years.
FY26: borrowings of ₹19.0 Cr against equity of ₹103 Cr — a debt-to-equity of 0.18. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹7.0 Cr to ₹19.0 Cr while capital spending ran ₹8.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Fabtech Cleanrooms Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — .
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Fabtech Cleanrooms Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gulshan Polyols LtdGULPOLY | 70.1/100Favorable setup87% evidence | ASLEEP | 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence | 19.5/25 ROCE 18.6% · OPM 13% 95% evidence | 14.3/20 P/E 6.8× · PEG — 50% evidence | 8.8/20 RS sector -1.7% · RS bench 2.8% · 1Y 9.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 19.5 + 14.3 + 8.8 = 70.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Sagility LtdSAGILITY | 67.3/100Favorable setup87% evidence | BREAKING OUT | 24.3/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.7/25 ROCE 13.4% · OPM 22% 100% evidence | 14.0/20 P/E 19.7× · PEG 1.02 65% evidence | 13.3/20 RS sector 7% · RS bench 1.4% · 1Y 0%6 of 12 weeks ahead 70% evidence |
| Exact sum: 24.3 + 15.7 + 14 + 13.3 = 67.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Exhicon Events Media Solutions Ltd543895 | 64.5/100Thin evidence · provisional60% evidence | BREAKING OUT | 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.6/25 ROCE 29.6% · OPM 28% 76% evidence | 11.9/20 P/E 20.8× · PEG — 50% evidence | 13.0/20 RS sector 2% · RS bench 9.8% · 1Y 15%5 of 12 weeks ahead 70% evidence |
| Exact sum: 19 + 20.6 + 11.9 + 13 = 64.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Global Education LtdGLOBAL | 63.9/100Mixed-positive evidence80% evidence | BREAKING OUT | 13.9/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence | 20.3/25 ROCE 29.2% · OPM 41% 95% evidence | 10.2/20 P/E 26.6× · PEG — 15% evidence | 19.5/20 RS sector 40.9% · RS bench 47.6% · 1Y 111.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 20.3 + 10.2 + 19.5 = 63.9 · Decision use: Price leads the evidence: RS versus the benchmark is 47.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 5Anlon Technology Solutions LtdANLON | 62.9/100Thin evidence · provisional51% evidence | TURNING | 23.1/35 Revenue 100% · PAT 100% · OPM change 1 pp 48% evidence | 19.8/25 ROCE 27.1% · OPM 20% 76% evidence | 7.5/20 P/E 41× · PEG — 50% evidence | 12.5/20 RS sector — · RS bench 58% · 1Y —1 of 1 week ahead 25% evidence |
| Exact sum: 23.1 + 19.8 + 7.5 + 12.5 = 62.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Aeroflex Enterprises LtdAEROENTER | 60.8/100Mixed-positive evidence87% evidence | FADING | 19.3/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence | 14.8/25 ROCE 12.6% · OPM 9% 95% evidence | 12.0/20 P/E 9.1× · PEG — 50% evidence | 14.7/20 RS sector 24.2% · RS bench 29.5% · 1Y 44.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 14.8 + 12 + 14.7 = 60.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7IIRM Holdings India Ltd526530 | 58.3/100Mixed-positive evidence75% evidence | FADING | 15.9/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence | 19.3/25 ROCE 20.4% · OPM 24.6% 76% evidence | 10.1/20 P/E 33.4× · PEG — 15% evidence | 13.0/20 RS sector 17.5% · RS bench 22.6% · 1Y 44.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 19.3 + 10.1 + 13 = 58.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Take LtdTAKE | 57.0/100Thin evidence · provisional59% evidence | 23.9/35 Revenue — · PAT -68.2% · OPM change 2932.2 pp 52% evidence | 11.0/25 ROCE 18.5% · OPM -0.9% 95% evidence | 10.0/20 P/E 38.9× · PEG — 15% evidence | 12.1/20 RS sector 69.8% · RS bench -48.7% · 1Y 48.7%11 of 12 weeks ahead 70% evidence | |
| Exact sum: 23.9 + 11 + 10 + 12.1 = 57 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9R K Swamy LtdRKSWAMY | 56.6/100Mixed-positive evidence65% evidence | 22.2/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence | 15.4/25 ROCE 12.3% · OPM 10.4% 95% evidence | 10.8/20 P/E 19.5× · PEG — 15% evidence | 8.2/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead to 2026-08-16 25% evidence | |
| Exact sum: 22.2 + 15.4 + 10.8 + 8.2 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Aegis Vopak Terminals LtdAEGISVOPAK | 55.8/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.7/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence | 13.3/25 ROCE 7.6% · OPM 77% 76% evidence | 8.9/20 P/E 119× · PEG — 15% evidence | 11.9/20 RS sector — · RS bench 27.8% · 1Y 19.4%12 of 12 weeks ahead 25% evidence |
| Exact sum: 21.7 + 13.3 + 8.9 + 11.9 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Prozone Realty LtdPROZONER | 55.4/100Mixed-positive evidence80% evidence | TURNING | 22.4/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence | 8.4/25 ROCE 6% · OPM -35.6% 95% evidence | 9.4/20 P/E 62.1× · PEG — 15% evidence | 15.2/20 RS sector 1.9% · RS bench 7% · 1Y 6.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 8.4 + 9.4 + 15.2 = 55.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Parin Enterprises LtdPARIN | 55.3/100Mixed-positive evidence63% evidence | TURNING | 19.3/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.7/25 ROCE 10.7% · OPM 9% 95% evidence | 8.8/20 P/E 121× · PEG — 15% evidence | 15.5/20 RS sector 8.9% · RS bench 14.2% · 1Y 39.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 11.7 + 8.8 + 15.5 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Anzen India Energy Yield Plus TrustANZEN | 50.0/100Mixed-positive evidence60% evidence | TURNING | 20.5/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence | 9.0/25 ROCE 3.3% · OPM 80% 76% evidence | 9.1/20 P/E 99.4× · PEG — 15% evidence | 11.4/20 RS sector — · RS bench 11% · 1Y 12.1%3 of 10 weeks ahead 25% evidence |
| Exact sum: 20.5 + 9 + 9.1 + 11.4 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Eveready Industries India LtdEVEREADY | 49.1/100Mixed-negative evidence94% evidence | ASLEEP | 18.4/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence | 13.7/25 ROCE 17.2% · OPM 15% 100% evidence | 9.0/20 P/E 14.5× · PEG 2.1 100% evidence | 8.0/20 RS sector -9.6% · RS bench 0% · 1Y -18.9%5 of 12 weeks ahead 70% evidence |
| Exact sum: 18.4 + 13.7 + 9 + 8 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15GMR Airports LtdGMRAIRPORT | 48.2/100Mixed-negative evidence74% evidence | ASLEEP | 22.3/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence | 11.2/25 ROCE 11.6% · OPM 37% 100% evidence | 8.6/20 P/E 175× · PEG — 15% evidence | 6.1/20 RS sector -4.7% · RS bench -0.1% · 1Y 7.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 11.2 + 8.6 + 6.1 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Jai Corp LtdJAICORPLTD | 48.2/100Mixed-negative evidence74% evidence | ASLEEP | 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence | 11.3/25 ROCE 11.8% · OPM 15% 95% evidence | 11.0/20 P/E 16.6× · PEG — 15% evidence | 6.3/20 RS sector -8.4% · RS bench -18.8% · 1Y -37.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 19.6 + 11.3 + 11 + 6.3 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17TCC Concept LtdTCC | 46.9/100Mixed-negative evidence81% evidence | BASING | 16.5/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.7/25 ROCE 5.7% · OPM 36% 95% evidence | 14.4/20 P/E 17.1× · PEG — 50% evidence | 4.3/20 RS sector -17.7% · RS bench -35.9% · 1Y -91.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.5 + 11.7 + 14.4 + 4.3 = 46.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Jindal Photo LtdJINDALPHOT | 45.6/100Mixed-negative evidence77% evidence | ASLEEP | 20.2/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence | 10.0/25 ROCE -1.4% · OPM 98% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.4/20 RS sector -14.9% · RS bench -10.5% · 1Y -6.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 10 + 10 + 5.4 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Inox Green Energy Services LtdINOXGREEN | 45.1/100Mixed-negative evidence75% evidence | ASLEEP | 22.0/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence | 9.2/25 ROCE 8.4% · OPM -2.2% 76% evidence | 9.6/20 P/E 54.4× · PEG — 15% evidence | 4.3/20 RS sector -12.9% · RS bench -8.7% · 1Y -21%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22 + 9.2 + 9.6 + 4.3 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20TruAlt Bioenergy LtdTRUALT | 44.0/100Mixed-negative evidence77% evidence | TURNING | 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.6/25 ROCE 10.4% · OPM 21% 100% evidence | 10.3/20 P/E 24.4× · PEG — 15% evidence | 13.4/20 RS sector 2.7% · RS bench 7.6% · 1Y -16.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.7 + 9.6 + 10.3 + 13.4 = 44 · Decision use: Price leads the evidence: RS versus the benchmark is 7.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Shipping Corporation of India Land & Assets LtdSCILAL | 43.9/100Mixed-negative evidence80% evidence | BASING | 23.9/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence | 4.9/25 ROCE 1.3% · OPM -14% 95% evidence | 9.5/20 P/E 59.9× · PEG — 15% evidence | 5.6/20 RS sector -17% · RS bench -12.9% · 1Y -26.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.9 + 4.9 + 9.5 + 5.6 = 43.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17% and the one-year return is -26.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 22Delta Corp LtdDELTACORP | 39.4/100Mixed-negative evidence81% evidence | TURNING | 9.4/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence | 8.6/25 ROCE 5.1% · OPM 18% 95% evidence | 13.4/20 P/E 12.8× · PEG — 50% evidence | 8.0/20 RS sector -18.2% · RS bench 17% · 1Y -8.6%2 of 12 weeks ahead 70% evidence |
| Exact sum: 9.4 + 8.6 + 13.4 + 8 = 39.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 23GKW LtdGKWLIMITED | 38.8/100Mixed-negative evidence71% evidence | ASLEEP | 10.5/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence | 8.9/25 ROCE 0.5% · OPM 84% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.4/20 RS sector -1.1% · RS bench -3.3% · 1Y -7.6%1 of 12 weeks ahead 70% evidence |
| Exact sum: 10.5 + 8.9 + 10 + 9.4 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Unitech LtdUNITECH | 37.4/100Mixed-negative evidence69% evidence | BASING | 17.7/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence | 3.5/25 ROCE 0.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.2/20 RS sector -21.9% · RS bench -18% · 1Y -44.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 3.5 + 10 + 6.2 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Aqylon Nexus LtdAQYLON | 36.1/100Mixed-negative evidence72% evidence | BASING | 18.4/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence | 9.2/25 ROCE 1.9% · OPM 58% 95% evidence | 8.5/20 P/E 552× · PEG — 15% evidence | 0.0/20 RS sector -81.3% · RS bench -80.2% · 1Y -83.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 9.2 + 8.5 + 0 = 36.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Shree Rama Newsprint LtdRAMANEWS | 36.1/100Mixed-negative evidence63% evidence | 9.0/35 Revenue -17.1% · PAT 35.9% · OPM change -19 pp 71% evidence | 3.0/25 ROCE 0.9% · OPM -8% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.1/20 RS sector 9.5% · RS bench 2.6% · 1Y -0.9%11 of 12 weeks ahead 70% evidence | |
| Exact sum: 9 + 3 + 10 + 14.1 = 36.1 · Decision use: Price leads the evidence: RS versus the benchmark is 2.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 27Kaveri Seed Company LtdKSCL | 33.8/100Adverse evidence94% evidence | ASLEEP | 11.0/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence | 12.9/25 ROCE 15.8% · OPM 40% 100% evidence | 4.8/20 P/E 14.7× · PEG 3.12 100% evidence | 5.1/20 RS sector -17.3% · RS bench -14.3% · 1Y -32.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11 + 12.9 + 4.8 + 5.1 = 33.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Stanley Lifestyles LtdSTANLEY | 29.7/100Adverse evidence74% evidence | ASLEEP | 6.0/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence | 10.9/25 ROCE 6.4% · OPM 17.3% 95% evidence | 9.0/20 P/E 113× · PEG — 15% evidence | 3.8/20 RS sector -43.8% · RS bench -17.4% · 1Y -54.1%4 of 12 weeks ahead 70% evidence |
| Exact sum: 6 + 10.9 + 9 + 3.8 = 29.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Embassy Developments LtdEMBDL | 28.2/100Adverse evidence64% evidence | ASLEEP | 5.8/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence | 3.4/25 ROCE -2.4% · OPM -60% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.0/20 RS sector -11.6% · RS bench -7.4% · 1Y -38.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 5.8 + 3.4 + 10 + 9 = 28.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30RattanIndia Enterprises LtdRTNINDIA | 17.4/100Adverse evidence74% evidence | BASING | 2.6/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence | 1.1/25 ROCE -4.8% · OPM 2.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.7/20 RS sector -32.2% · RS bench -24.5% · 1Y -51.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 2.6 + 1.1 + 10 + 3.7 = 17.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Central Mine Planning & Design Institute LtdCMPDI | 63.6/100Thin evidence · provisional40% evidence | ASLEEP | 22.4/35 Revenue — · PAT — · OPM change 8 pp 34% evidence | 20.8/25 ROCE 38.1% · OPM 30% 100% evidence | 10.4/20 P/E 22.3× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence |
| Exact sum: 22.4 + 20.8 + 10.4 + 10 = 63.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Fabtech Cleanrooms Ltdthis page544332 | 57.3/100Thin evidence · provisional36% evidence | BREAKING OUT | 17.6/35 Revenue — · PAT — · OPM change 2 pp 26% evidence | 17.4/25 ROCE 19.4% · OPM 12% 76% evidence | 9.9/20 P/E 40.4× · PEG — 15% evidence | 12.4/20 RS sector — · RS bench 53.5% · 1Y —11 of 11 weeks ahead 25% evidence |
| Exact sum: 17.6 + 17.4 + 9.9 + 12.4 = 57.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Qualitek Labs Ltd544091 | 54.3/100Thin evidence · provisional29% evidence | BREAKING OUT | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 15.0/25 ROCE 12.1% · OPM 26% 76% evidence | 9.7/20 P/E 49.1× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 51% · 1Y —7 of 9 weeks ahead 25% evidence |
| Exact sum: 17.3 + 15 + 9.7 + 12.3 = 54.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Shree Vasu Logistics LtdSVLL | 51.5/100Thin evidence · provisional50% evidence | BREAKING OUT | 18.0/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence | 15.8/25 ROCE 12.9% · OPM 25.8% 95% evidence | 8.7/20 P/E 126× · PEG — 15% evidence | 9.0/20 RS sector -16.3% · RS bench 22.6% · 1Y 4%12 of 12 weeks ahead 70% evidence |
| Exact sum: 18 + 15.8 + 8.7 + 9 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Indiqube Spaces LtdINDIQUBE | 49.4/100Thin evidence · provisional49% evidence | BREAKING OUT | 18.4/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence | 9.5/25 ROCE 6.4% · OPM 61% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.5/20 RS sector — · RS bench 13.6% · 1Y -13.9%7 of 12 weeks ahead 25% evidence |
| Exact sum: 18.4 + 9.5 + 10 + 11.5 = 49.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Maagh Advertising & Marketing Services Ltd543624 | 49.3/100Thin evidence · provisional35% evidence | 18.3/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 8.9/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.1/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.3 + 8.9 + 10 + 12.1 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 37Tandhan Industries Ltd512062 | 45.9/100Thin evidence · provisional33% evidence | FADING | 20.1/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.5/25 ROCE -0.3% · OPM 15.8% 76% evidence | 9.3/20 P/E 67.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —11 of 12 weeks ahead 0% evidence |
| Exact sum: 20.1 + 6.5 + 9.3 + 10 = 45.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Fabtech Cleanrooms Ltd's share price today?
Fabtech Cleanrooms Ltd trades at ₹494. The company is valued at ₹609 Cr. The stock sits at 92% of its 52-week range of ₹277–₹513, +32.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 17 weeks in. — as of 1 October 2026.
What were Fabtech Cleanrooms Ltd's latest quarterly results?
Fabtech Cleanrooms Ltd reported revenue of ₹143 Cr and net profit of ₹13.0 Cr for the Mar 26 quarter. Revenue rose 62.5% and profit rose 62.5% year on year. Earnings per share were ₹10.14. The operating margin was 12.0%, 2.0 pp higher than a year earlier. — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's revenue?
Fabtech Cleanrooms Ltd reported revenue of ₹143 Cr in the Mar 26 quarter, +62.5% year on year. For the full FY26 fiscal year, revenue was ₹219 Cr (+46.0%). Over the last 6 years revenue compounded at 16.2% a year. — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's profit?
Fabtech Cleanrooms Ltd earned ₹13.0 Cr of net profit in the Mar 26 quarter, +62.5% year on year. Full-year FY26 profit was ₹17.0 Cr. The operating margin ran 12.0% in the latest quarter. — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's market cap?
Fabtech Cleanrooms Ltd's market capitalisation is ₹609 Cr at a share price of ₹494. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's P/E ratio?
Fabtech Cleanrooms Ltd trades at a P/E of 40.4×, at the 97th percentile of its own 2-year range, against a long-run median of 29.5×. This is a comparison with the stock's own history, not a value call — as of 1 October 2026.
Does Fabtech Cleanrooms Ltd pay a dividend?
Not in its latest year — Fabtech Cleanrooms Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 1 of its last 7 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd overvalued?
On its own history, Fabtech Cleanrooms Ltd looks expensive: its P/E of 40.4× sits at the 97th percentile of its 2-year range (long-run median 29.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd growing?
Yes — Fabtech Cleanrooms Ltd is growing: latest-quarter revenue +62.5% year on year, profit +62.5%, and the margin +2.0 pp at 12.0%. The 6-year compound rates are 16.2% (revenue) and 27.3% (profit). The earnings engine currently reads: improving — as of 1 October 2026.
How is Fabtech Cleanrooms Ltd performing?
Fabtech Cleanrooms Ltd is in a confirmed uptrend, 17 weeks in. Its latest quarter's revenue rose 62.5% and profit rose 62.5% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 17 of stage 2), trading +32.3% versus its 200-day average and at 92% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd beating the market?
On recent form, yes — Fabtech Cleanrooms Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5 months the stock moved +79% against the NIFTY 500's −4% — ahead of the index over the full window. — as of 1 October 2026.
Will Fabtech Cleanrooms Ltd's share price go up?
This page publishes no price forecast for Fabtech Cleanrooms Ltd. What it measures instead: the share price is ₹494, the price is in a confirmed uptrend 17 weeks in. Its P/E of 40.4× sits at the 97th percentile of its own 2-year range. — as of 1 October 2026.
Who owns Fabtech Cleanrooms Ltd?
Promoters hold 68.5% of Fabtech Cleanrooms Ltd, foreign institutions 0.0%, domestic institutions 6.4% and the public 25.1% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 1 October 2026.
Does Fabtech Cleanrooms Ltd have too much debt?
No — Fabtech Cleanrooms Ltd's debt-to-equity is 0.18, and operating profit covers the interest bill 11×. FY26 borrowings were ₹19.0 Cr against equity of ₹103 Cr. The returns on this page are earned, not borrowed — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's capex?
Fabtech Cleanrooms Ltd spent ₹8.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹7.0 Cr, with ₹1.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 1 October 2026.
What is Fabtech Cleanrooms Ltd's cash flow?
Fabtech Cleanrooms Ltd consumed ₹17.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−24.0 Cr). Operating cash was negative while the company reported a profit of ₹17.0 Cr. Cash-flow resolution for India is annual. — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Fabtech Cleanrooms Ltd consumed cash while reporting profit. In FY26, operating cash was ₹−17.0 Cr against reported profit of ₹17.0 Cr. Cash-flow resolution is annual — as of 1 October 2026.
Where is Fabtech Cleanrooms Ltd in its business cycle?
Fabtech Cleanrooms Ltd's FY26 operating margin was 10.0%, against a 7-year band of 2.1%–11.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 12.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 1 October 2026.
What could break the Fabtech Cleanrooms Ltd story?
The sharpest disagreement: profits are rising, but only −31% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 1 October 2026.
Is Fabtech Cleanrooms Ltd a stock worth studying right now?
This is not investment advice. The machine read: Fabtech Cleanrooms Ltd is strength at full price. The numbers are improving — and a P/E at the 97th percentile of its own range says the market knows. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 1 October 2026.
Not SEBI Registered !! Not Investment advice !!